Beyond the Peace of Old Age: Aging, Longevity, Capital, and the New Frontiers of Power
Image source: Getty Images
An informal conversation between Russian President Vladimir Putin and Chinese leader Xi Jinping, to choose It was lifted by the microphone of Chinese state television in September 2025, leading to renewed discussions about biotechnological approaches to extending human lifespan. While some observers have dismissed the discussion as beyond the reach of science, especially on the topic of immortality, it instead points to an anti-aging research agenda that is slowly building up. Both countries have adopted policies on healthy aging, especially in the past two decades, and continue to invest Significantly In technologies such as gene editing and 3D bioprinting to target the aging process at the cellular level. while Speculation While the validity and potential of some studies have been highlighted, anti-aging research has strategic implications; Similar health-oriented research ecosystems are evident in the United States and India, where researchers and biotechnology companies are investing in ways to slow the aging process and prevent the onset of chronic and debilitating diseases. Altogether, these developments point to the emergence of “longevity capital” – the set of technological and industrial investments directed toward extending human lifespan.
Aging and the Limits of Aging Peace
Many states are experiencing demographic shifts, with aging populations becoming more common. With declines in fertility rates and increases in life expectancy emerging as causal factors, the World Health Organization (WHO) decided Estimates By 2030, there will be 1.4 billion people over the age of 60. studies displays Although life expectancy has nearly doubled since 1960, people still spend 50% of their lives in poor or fair health. Countries have begun to focus on strategy repercussions Demographic shifts where population provides economic security and constitutes the basic unit of a state’s military capacity. As populations age, military capabilities may gradually diminish, causing states to focus more on improving citizens’ quality of life.
In developing the concept of “peace of old age,” Haass argued that Russia and China were unlikely to engage in conflict with the United States, because the demographic challenges they faced would restrict economic growth, crowd out military spending in favor of care for the elderly, and reduce the military age range.
In his book, Old Age Peace: Aging Populations and the Decline of War, Mark L. Haas, American political scientist. Argue As the populations of major economies age, the likelihood of engaging in hot or cold wars will diminish as fewer people and resources become available. In developing the concept of “peace of old age,” Haass argued that Russia and China were unlikely to engage in conflict with the United States, because the demographic challenges they faced would restrict economic growth, crowd out military spending in favor of care for the elderly, and reduce the military age range. Thus, as these powers grow older, their diminished military capabilities will force them to pursue more peaceful foreign policy agendas. He assumed that states would adopt less militarized strategies by shifting money away from military spending, allocating more money to social security (for example, elder care), and entering into security partnerships.
Haas’s idea of the peace of old age has not changed Completely You are right. For example, Russia’s effort to confront what it sees as NATO’s expansionist motives, starting from the attack on Georgia in 2008 to the ongoing conflict in Ukraine, It is clear How population aging does not necessarily prevent leaders from showing more restraint in their foreign policies. Instead, concerns about demographic decline may prompt countries to act more assertively to secure their interests. Moreover, as speculation grows surrounding China’s potential invasion of Taiwan, demographic factors are likely as well insufficient To prevent countries from entering into conflicts.
Russia’s efforts to counter what it sees as NATO’s expansionist impulses, from the 2008 attack on Georgia to the conflict in Ukraine, demonstrate how aging populations do not necessarily prevent leaders from showing more restraint in their foreign policies. Instead, concerns about demographic decline may prompt countries to act more assertively to secure their interests.
Traditional responses to demographic decline have focused on increasing fertility rates, reforming pension systems, and changing immigration policies. But more recently, the demographic has been aging as well Been watched And more from a scientific and technological perspective, with countries allocating more resources to developing technologies that will slow the aging process or help people live longer. As aging demographics raise questions about economic competitiveness and resilience, countries are gradually shifting their focus toward technologies that can mitigate some of the effects of aging.
From population aging to the science of longevity
In an aging population, it is expected Labor force participation will decline, leading to decreased economic productivity and increased health care spending. Given this situation, ways to extend the number of years that individuals can be healthy and productive are attractive. Longevity science aims to improve the quality of life in aging societies beyond social care and health care. While researchers have long worked to prevent disease and improve public health, the COVID-19 pandemic Proven How quickly new biomedical innovations can be developed when governments see a threat to public health and economic stability, and how willing people are to change their lifestyles to live longer, healthier lives. In doing so, it has highlighted the potential for scientific advances to address the intersection between aging, longevity and well-being.
While researchers have long worked to prevent disease and improve public health, the COVID-19 pandemic has shown how quickly new biomedical innovations are developed when governments see a threat to public health and economic stability, and how willing people are to change their lifestyles to live longer, healthier lives.
Aging research, or Earth scienceIt focuses on identifying and understanding the biological mechanisms responsible for aging, how to slow it, prevent age-related diseases, and extend human health. For example, gerontology views aging as a risk factor for conditions such as cardiovascular disease, cancer, and neurodegenerative diseases, and works by targeting the underlying aging process. A major milestone happened in 2013, and then 2023When scientists identified and classified Distinctive features of aging – Interconnected cellular and molecular mechanisms responsible for the aging process – Empowerment Researchers To study the factors causing age-related disorders more systematically. As a result, efforts in this field have focused on understanding how to track, delay, or reverse aging. Gerontology views aging as a treatable biological process that can be modified by adopting preventive interventions, lifestyle modifications, and therapeutic agents, aimed at extending the period of health.
Longevity capital
Growing interest Advances in environmental science have been accompanied by increased investments by governments, venture capital firms, and biotechnology companies. term “Longevity Capital” These financial, technological and institutional investments aim to extend health and delay the aging process. However, so is aging research preciseBecause aging itself is not recognized as a disease by the World Health Organization. Since it is not recognized as a direct therapeutic indication, clinical trials focus on factors that contribute to age-related diseases. Research and development to focus On biomarkers – to diagnose age-related diseases, identify risk factors, and determine treatment outcomes.
Drug discovery by targeting the molecular mechanisms that drive aging is another avenue of research that has been accelerated by its convergence with artificial intelligence. For example, New limit It aims to develop drugs that implement Genetic reprogramming – Epigenetic modifications are changes that occur to DNA during the aging process – to reverse cell aging. HexemBio She developed the artificial human yolk sac platform as road To replenish blood stem cells, allowing the production of healthier white blood cells, red blood cells and platelets for a healthy lifespan. Altos Labs is investigating the use of an immunosuppressive drug, rapamycin, in Slow down Senescence (or cellular senescence) in animal models.
These financial, technological and institutional investments, called “longevity capital,” aim to extend health and delay the aging process. However, aging research is still nuanced, as the World Health Organization does not recognize aging itself as a disease. Since it is not recognized as a direct therapeutic indication, clinical trials focus on factors that contribute to age-related diseases.
Beyond the private sector, governments and research organizations are building their long-term research systems. In the United States, Advanced Research Projects Agency for Health (ARPA-H), an agency of the Department of Health and Human Services, dedicated to advanced biomedical innovation for life extension. Its programme, Proactive Solutions to Extend Resilience (PROSPR). Granted US$144 million to fund studies on aging-related interventions. Longevity India, a initiative The Indian Institute of Science (IISc), reflects India’s commitment to understanding and addressing the challenges of demographic shifts. Together, these efforts indicate that longevity is gradually becoming part of biotechnology innovation ecosystems.
Rethinking aging
While the candid conversation between Putin and Xi has been widely dismissed as speculation about immortality, there are more significant developments regarding longevity. Governments, research institutions, and biotechnology companies are increasingly focusing on increasing human lifespan by slowing the aging process and preventing the onset of age-related diseases. As demographics become aging, longevity research has become an integral part of biotechnology innovation ecosystems. The emergence of longevity capital, advances in gerontology, and the convergence with artificial intelligence suggest that aging is treated as a treatable biological process. In this way, the future of longevity will revolve around how societies adapt to an aging world.
Lakshmi Ramakrishnan He is an associate fellow at the Center for New Economic Diplomacy at the Observer Research Foundation.
Disclaimer: The author acknowledges the use of OpenAI-GPT-5.5 for proofreading and language editing suggestions.
The opinions expressed above are those of the author(s). ORF research and analysis is now available on Telegram! Click here To access our curated content – blogs, longforms, and interviews.




